PSMA-617
Phase 2- Indications
- Metastatic castration-resistant prostate cancer
Company intelligence / Profile preview
BIOMEDRO provides contract research services spanning preclinical to clinical studies. The institute specializes in developing analytical methods, biological models, encapsulation technologies for new actives, and improving bioavailability—especially relevant to antibody therapeutics. It positions itself between basic academic research and industrial high-throughput CROs by offering flexible solutions tailored to client needs. No proprietary therapeutic programs or late-stage assets are reported publicly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomedizinische Forschungs.